Simple predictors in identifying bacterial pneumonia in children aged 6 months to 60 months by Suresh, P
SIMPLE PREDICTORS IN IDENTIFYING BACTERIAL 
PNEUMONIA IN CHILDREN AGED   6 MONTHS TO 60 
MONTHS
Dissertation Submitted for
M.D. DEGREE EXAMINATION
BRANCH VII – PAEDIATRIC MEDICINE
INSTITUTE OF CHILD HEALTH
AND
HOSPITAL FOR CHILDREN
MADRAS MEDICAL COLLEGE
THE TAMIL NADU Dr. M.G.R. MEDICAL UNIVERSITY
CHENNAI
MARCH – 2008
CERTIFICATE
Certified  that  this  dissertation  entitled  “SIMPLE  PREDICTORS  IN 
IDENTIFYING BACTERIAL PNEUMONIA IN CHILDREN AGED 6 MONTHS 
TO 60 MONTHS” is  a  bonafide  work done  by  Dr.  P.  Suresh,  M.D.  Postgraduate 
student  of  Pediatric  Medicine,  Institute  of  Child  Health  and  Hospital  for  Children, 
Egmore,  Chennai –8 attached to Madras Medical College, during the academic years 
2005-2008.
Prof. Dr. Saradha Suresh, M.D., Ph.D., 
F.R.C.P.(Glas),
Director and Superintendent (I/C),
Head of Department and Professor of 
Pediatrics,
Institute of Child Health and Hospital for 
Children,
Madras Medical College,
Chennai.
Prof. Dr. T.P.Kalaniti, M.D.,
Dean,
Madras Medical College,
Chennai.
SPECIAL ACKNOWLEDGEMENT
 My sincere thanks to Prof. Dr. T.P. KALANITI M.D., Dean, Madras Medical 
College and Research Institute for allowing me to do this dissertation and utilize the 
institutional facilities.
ACKNOWLEDGEMENT
I  would  like  to  express  my  sincere  gratitude  to   
Prof.   Dr. SARADHA  SURESH, M.D., PhD., FRCP.,  Professor  of  Paediatrics,  Director  and 
Superintendent  (I/C)  of  Institute  of  Child  Health  and  Hospital  for  Children  for  permitting  me  to 
undertake this study.
I  would  like  to  thank  my  unit  Assistant  Professors  of  Paediatrics, 
Dr.RAVICHANDRAN.,  M.D.,  D.C.H.,   Dr.K.SUGUNA,  MD.,DCH.,  Dr. 
ELILARASI., M.D.,DCH and Dr. SUDAKAR.  M.D., for their valuable guidance and 
assistance in doing this work.
I would like to thank  Dr. K.  NEDUNCHELIAN M.D., D.C.H.,  for his valuable suggestion 
and guidance in doing this study. . 
I extend my sincere thanks to Dr. P. RAMACHANDRAN,        M.D., D.C.H., Registrar for 
his valuable suggestion and guidance in doing this work. 
I sincerely thank all the children and their parents who had submitted themselves for this study 
without whom this study would not have been possible. 
CONTENTS 
SL.NO. TITLE PAGE NO.
1. INTRODUCTION 1
2. REVIEW OF LITERATURE 17
3. STUDY JUSTIFICATION 23
4. AIM OF THE STUDY 24
5. SUBJECTS AND METHODS 25
6. STATISTICAL ANALYSIS 33
7. RESULTS 34
8. DISCUSSION 48
9. CONCLUSION 53
BIBLIOGRAPHY
ANNEXURE
                                                                    INTRODUCTION
Infections of the respiratory tract are perhaps the most common human ailments. 
Acute  Respiratory  Infections  (ARI)  have  quite  a  high  morbidity  and  mortality  in 
children in developing countries1. On an average, children below 5 years of age suffer 
about 5 episodes of ARIs annually regardless of, where they live, or what their economic 
situation is, (Kamath and others, 1969, Monto and Ullman 1974) thus accounting for 
about  228  million  attacks,  although  most  of  the  attacks  are  mild  and  self  limiting 
episode. ARI is responsible for about 30-50 percent of visits to health facilities and for 
about 20-40 percent of hospital admissions. Pneumonia is a leading cause of mortality in 
children worldwide. Estimates of the mortality burden are problematic.
The  World Health  Organization (WHO) propose  2-6 million  childhood deaths 
annually  attributed  to  acute  lower  respiratory  tract  illnesses  (ALRI)2.  Although  the 
delivery of current and new vaccines is obviously a key issue in the control of ALRI, 
case management has been the mainstay of international attempts to reduce this burden 
of disease. During last 20 years, many countries have implemented the case management 
algorithms developed by the WHO. There is good evidence that such programs have 
reduced mortality from this condition in developing countries3.  In the last few years, 
these and other disease- specific algorithms have been incorporated into the integrated 
management of childhood illness approach that has been developed by the WHO. 
The primary purpose of such an algorithm is to prevent mortality due to bacterial 
pneumonia. However an unknown proportion of children managed in this fashion will 
have a viral related wheezing illness or asthma, rather than pneumonia. Although it is 
unlikely that wheezing syndromes are  a significant cause of mortality for children in 
developing countries, these algorithms are likely to result in unnecessary administration 
of  antibiotics  as  well  as  inadequate  treatment of  recurrent  wheezing illness.  If  these 
issues  are  to  be  tackled,  we  need  to  carefully  review  the  existing  evidence  about 
wheezing illness in early life.
There are only a small number of population- based studies on natural history that 
assess symptoms and lung function in the first six years of life. All these studies are 
from developed countries. The most important of these is the Tuscan Children Respira - 
studies  commenced  in  the  early  1980s  in  Arizona,  USA4.  This  group  prospectively 
enrolled 1246 newborn children in 1980. Follow-up data was available at both 3 and 6 
years of age for 826 children. This study demonstrated that almost 60% of children who 
were in the first few years of life have ceased wheezing by age 6. Most children with 
wheeze in the first three years of life have a transient syndrome that may be related to 
pre-existing reduced airway function at birth and this condition is not associated with 
features of atopy or future development of asthma.
Non-asthmatic  wheeze  in  early  childhood  is  associated  with  intercurrent  viral 
illness. The risk factors for this syndrome appear to be:
 Reduced lung function that may reflect impaired lung growth in the intrauterine period.
 Exposure to tobacco smoke either during the prenatal or early childhood period 4,5
In  both  developed  and  developing  countries,  respiratory  
Syncytial virus is the predominant etiological agent often responsive for bronchiolitis 
and wheezing illness in the first 2 years of life  6,7. Moreover data from several studies 
demonstrate that RSV infection and the bronchiolitis syndrome are a major component 
of the total ALRI in children living in developing countries. The relevant literature on 
therapy includes studies in which children were labeled as bronchiolitis and others in 
which children were classified as wheezing illness.
Unfortunately  we  do  not  have  clear  evidence  about  whether  antibiotics  can  be 
withheld in some categories of children with tachypnea. It is clear that tachypnea occurs 
in bacterial infection and in addition, co-infection with virus and bacteria has been well 
demonstrated  in  several  studies  on  pneumonia  etiology  in  children.  Although  some 
studies have found that  children with more severe disease or  who are  blood culture 
positive are more likely to be febrile at the time of presentation, these signs are not 
sufficiently sensitive or specific to determine whether antibiotics should be administered 
8,9. 
There is substantial evidence that the prevalence of hyper-reactive airway disease is 
increasing worldwide both in developed and developing countries. A study conducted by 
a pediatric pulmonologist in metropolitan cities showed steady rise of prevalence from 
9% to 29.5% 10,11. This steady rise in prevalence correlated with demographic changes in 
this city like increase in industries, increased density of population from migration of 
rural  population in search of jobs and increased number of automobiles to commute 
resulting in air pollution. 
The  study  concluded  that  allergic  respiratory  disorders  in  particular  asthma  are 
increasing  in  the  developing  countries  and  pose  a  serious  global  health  problem in 
children and economic burden  11.  WHO developed the programme for the control of 
respiratory infections in 1980s which was included as a component of the integrated 
management of childhood illness strategy in the mid 1990s  12.  This strategy includes 
utilization of simple clinical signs and symptoms with high sensitivity and specificity to 
be  adopted  at  first  level  health  facilities  by  paramedical  personnel  12.  Using  this 
algorithm, pneumonia is diagnosed by the presence of tachypnea defined as respiratory 
rate >60 breaths / minute among children aged <2 months, >50 breaths / minute among 
children aged 2-11 months and >40 breaths / minute among the children aged 12-59 
months. 
Because  mortality  due  to  pneumonia  in  developing  countries  is  attributable 
mainly to bacterial etiology, IMNCI strategy recommends the use of antibiotics when a 
child presented with tachypnea as defined previously  12. Despite the proven benefit of 
this programme, there has been some concern about specificity of the WHO pneumonia 
algorithm and IMNCI leading to unnecessary use of antibiotics in regions with high 
prevalence of wheezing illness 14. 
In this context, it is also important to consider that asthma and other wheezing 
illness do occur and they can be diagnosed in children who present with cough and 
difficult breathing and they can be treated with only bronchodilators without the need 
for antibiotics  15. The study was designed to evaluate the potential use of fever, chest 
indrawing  and  the  effect  of  bronchodilator  response  in  children  with  cough  and 
tachypnea as tools to exclude the diagnosis of pneumonia and thus to refine the use of 
antibiotics.
Acute respiratory infections in children:
Acute  respiratory  infections  (ARIs)  are  classified  as  upper  respiratory  tract 
infection (URIs) or lower respiratory tract infections (LRIs). The upper respiratory tract 
consists of the airways from the nostrils to the vocal cords in the Larynx, including the 
paranasal sinuses and the middle ear. The lower respiratory tract covers the continuation 
of the airways from the trachea and bronchi to the bronchioles and the alveoli. ARIs are 
not  confined  to  the  respiratory  tract  and  have  systemic  effects  because  of  possible 
extension of infection or microbial toxins, inflammation, and reduced lung function.
ARIs are the most common cause of both illness and mortality in children under 
five, who average three to six episodes of ARIs annually regardless of where they live or 
what  their  economic  situation  is.  However  the  proportion  of  mild  to  severe  disease 
varies  between high and low income countries  resulting  in  higher  case fatality  rate. 
Although medical care can to some extent mitigate both severity and fatality, estimates 
indicate that in 2000, 1-9 million of them died because of ARIs, 70 percent of them in 
Africa and South East Asia (Williams and Other 2002). The World health organization 
with estimates that 2 million children under five die of pneumonia in each year (Bryce 
and others 2005)16
Causes of ARIs and burden of disease:
ARIs in children take a heavy toll in life, especially where medical care is not 
available or is not sought.
Upper respiratory tract infections:
URIs are the most common infectious disease. They include Rhinitis (Common 
cold), sinusitis, ear infections, acute pharyngitis or tonsillo pharyngitis, epiglotitis and 
laryngitis of which ear infections and pharyngitis cause the more severe complications 
(deafness and acute rheumatic fever respectively). The vast majority of URIs have a 
viral etiology. Rhinoviruses account for 25 to 30 percent of URIs respectively syncytial 
viruses  (RSVS),  parainfluenza  and  influenza  viruses,  human  metapneumovirus,  and 
adenoviruses for 25 to 35 percent, corona virus for 10 percent and unidentified viruses 
for  the  remainder  (Denny,  1995).  Because  most  URIs  are  self  limiting,  their 
complications are more important than the infections. Acute viral infection predisposes 
children to bacterial infections of the sinuses and middle ear, and aspiration of infected 
secretions and cells which can result in LRIs (Berman, 1995)17.
Acute Pharyngitis:
Acute Pharyngitis is caused by viruses in more than 70 percentage of cases in 
young  children.  Mild  pharyngeal  redness  and  swelling  and  tonsil  enlargement  are 
typical. Streptococcal infection is rare in children under five and more common in older 
children. In countries with over-crowded living conditions and population that may have 
a genetic predisposition, post streptococcal sequelae such as rheumatic fever and carditis 
are common in school age children but may also occur in those under five.
Acute Ear Infections:
Acute ear infection occurs with upto 30 percent of URIs. In developing countries 
with inadequate medical care, it may lead to perforated eardrums and chronic discharge 
in later childhood and ultimately to hearing impairment or deafness (Berman 1995b)17. 
Chronic ear infection following repeated episodes of acute ear infection is common in 
developing countries affecting hearing which may be disabling and may affect learning. 
Repeated ear infections may lead to mastoiditis, which in turn may spread infection to 
the  meninges.  Mastoiditis  and  other  complications  of  URIs  account  for  nearly  5 
percentage of all ARI deaths worldwide (Williams and others 2002)18.
Lower Respiratory tract infections:
The common LRIs in children are pneumonia and bronchiolitis. Respiratory rate 
is a valuable clinical sign for diagnosing acute LRI in children who are coughing and 
breathing rapidly. The presence of lower chest wall indrawing identifies more severe 
disease (E. Mulholland and Others, 1992; Shann, Heart and Thomas, 1984)19. 
Currently,  the most  common causes of  viral  LRIs are RSVs. They tend to be 
highly seasonal; parainfluenza viruses are the next most common cause of viral LRIs. 
The  epidemiology  of  influenza  viruses  in  children  in  developing  countries  deserves 
urgent investigations because safe and effective vaccines are available.
Pneumonia:
Both bacteria  and viruses  can cause  pneumonia.  Bacterial  pneumonia  is  often 
caused by streptococcus pneumoniae (pneumococcus) or haemophilus influenza mostly 
type b (Hib) and occasionally by staphylococcus aureus or other streptococcus. Just 8 to 
12  of  the  many  types  of  pneumococcous  cause  most  cases  of  bacterial  pneumonia 
although specific types may vary between adults and children and between geographic 
locations. Other pathogens such as mycoplasma pneumonia and chlamydia pneumonia 
cause atypical pneumonias.
Upper respiratory tract  colonization with potentially pathogenic  organisms and 
aspiration of the contaminated secretions have been implicated in the pathogenesis of 
bacterial  pneumonia  in  young children.  Infection of  the  upper  respiratory  tract  with 
influenza virus or RSVs has been shown to increase the binding of both H. influenza 
(Jiang and others,  1999)20 and  streptococcus  pneumoniae  (Hament  and others  2004; 
McCuller and Bartmess)21 to lining cells in the nasopharynx. 
This finding may explain the increased rates of pneumococcal pneumonia parallel 
to  influenza  and  RSV  epidemics.  Viruses  are  responsible  for  40  to  50  percent  of 
infection in infants and children hospitalized for pneumonia in developing countries. 
Measles virus, RSV, parainfluenza viruses, influenza type A virus and adenoviruses are 
the most important cause of viral pneumonia. Differentiating between viral and bacterial 
pneumonias radiologically is difficult, partly because the lesions look similar and partly 
because bacterial  super-infection occurs with influenza,  measles,  and RSV infections 
(Ghafoer and Others, 1990)22.
Bronchiolitis:
Bronchiolitis  occurs  predominantly  in  the  first  year  of  life  with   decreasing 
frequency in the second and third years. The clinical features are rapid breathing and 
lower chest wall indrawing, fever in one-third of cases and wheezing (cherian and Other, 
1991)23. Inflammatory obstruction of the small airways, which leads to hyperinflation of 
the lungs and collapse of segments of the lung occur. Because the signs and symptoms 
are also characteristic of pneumonia, health workers may find differentiating between 
bronchiolitis  and  pneumonia  difficult.  Two  features  may  help  are  a  definition  of 
seasonality of RSV in the locality and the skill to detect wheezing.  RSV is the main 
cause of bronchiolitis worldwide and can cause upto 70 to 80 percent of LRIs during 
high season (Simoes, 1999, Stentralle, Devasundram and Simoes 2003)24. The recently 
discovered human metapneumovirus also causes bronchiolitis that is indistinguishable 
from RSV disease. Other viruses that cause bronchiolitis include para-influenza virus 
type 3 and influenza viruses.
Interventions:
Interventions to control ARIs can be divided into four basic categories:
 Immunization against specific pathogens.
 Early diagnosis and treatment of disease.
 Improvement in nutrition.
 Safer environments.
Vaccinations:
Widespread  use  of  vaccines  against  measles,  diphtheria,  pertussis,  Hib, 
pneumococcus, and influenza have the potential to substantially reduce the incidence of 
ARIs in children in developing countries.
The  efficacy  of  Hib  vaccine  in  preventing  invasive  disease  has  been  well 
documented in several studies in industrialized countries.
In developing countries, the vaccine is likely to have greater effect in preventing 
LRIs, including bacteraemic pneumonia.
Case management:
The simplification and systematization of case management for early diagnosis 
and treatment of ARI have enabled significant  reductions in mortality in developing 
countries  where  access  to  pediatricians  is  limited.  WHO  guidelines  for  ARI  care 
management (WHO, 1991) use two key clinical signs- respiratory rate to distinguish 
children with pneumonia from those without, and lower chest wall indrawing to identify 
severe  pneumonia  requiring  referral  and  hospital  admission.  Children  without  these 
signs are  classified as  having ARI but  not  pneumonia.  Children showing only rapid 
breathing are  treated  for  pneumonia.  Children with pneumonia are  treated with out-
patient antibiotic therapy. Children who have cough for more than 30 days are referred 
for further assessment of tuberculosis and other chronic infection.  
Pneumonia Diagnosis based on rapid breathing:
The  initial  guidelines  for  detecting  pneumonia  based  on rapid  breathing  were 
developed in Papua New Guinea during the 1970s. WHO recommends a respiratory rate 
cut-off of 50 breaths per minute for infants aged 2 through 11 months and 40 breaths per 
minute for children age 12 months to 5 years.
Rapid breathing as defined by WHO, defects about 85 percent of children with 
pneumonia, and more than 80 percent of children with potentially fatal pneumonia are 
probably  successfully  identified  and  treated  using  the  WHO  diagnostic  criteria. 
Antibiotic  treatment  of  children  with  rapid  breathing  has  been  shown  to  reduce 
mortality. The problem of the low specificity of the rapid breathing criterion is that some 
70 to 80 percent of children who may not need antibiotics will receive them.
Pneumonia diagnosis based on Chest wall indrawing:
Children are admitted to hospital  with severe pneumonia when health workers 
believe that oxygen or parenteral antibiotics are needed or when they lack confidence in 
the mother’s ability to cope. The rationale of parenteral antibiotics is to achieve a higher 
level of antibiotics and to overcome concerns about the absorption of oral drugs in ill 
children.
The papua new guinea study (Shann, Harl and Thomas 1984)25 used chest wall 
indrawing as the main indicator of severity, but studies from different parts of the world 
show  larger  differences  in  the  rates  of  indrawing  because  of  variable  definitions. 
Restriction of the term to lower chest wall indrawing, defined as inward movement of 
the bony structures of chest wall with inspiration has provided a better indicator of the 
severity of pneumonia and one that can be taught to health workers. It is more specific 
than intercostal indrawing which frequently occurs in bronchiolitis.
Studies in the Philippines and Swaziland (E. Mulholand and other, 1992)19 found 
that  lower  chest  wall  indrawing  was  more  specific  than  intercostal  indrawing  for  a 
diagnosis  of  severe  pneumonia  requiring  hospital  admission.  In  the  Vellore  study 
(Cherian and Other, 1988)26 lower chest wall indrawing correctly predicts 79 percent of 
children with LRI who were hospitalised by a pediatrician.
Antimicrobial options for oral treatment of pneumonia:
The choice of an antimicrobial drug for treatment is based on the well established 
findings that most childhood bacterial pneumonia are caused by S. pneumoniae or H. 
influenza. WHO has technical documents to help assess the relevant factors in selecting 
first and second line antimicrobials and comparisons of different microbials in relation 
to their antibacterial activity, treatment efficacy and toxicity.
The emergence of antimicrobial resistance in S.pneumoniae and H. influenzae is a 
serious concern. In some settings, in-vitro tests show more than 50 percent of respiratory 
isolates  of  both  bacteria  resistant  to  co-trimoxazole,  and  penicillin  resistance  to  S. 
pneumoniae is gradually becoming a problem worldwide. Amoxycillin is concentrated 
in tissues and in macrophages and drug levels are directly correlated with oral dosages. 
Therefore  higher  doses  than  in  the  past  given  twice  a  day  are  now  being  used  to 
successfully treat ear infections caused by penicillin resistant S.pneumoniae and in the 
face  of  higher  rates  of  cotrimoxazole  resistance,  amoxycillin  may  be  superior  for 
children with severe pneumonia.
Treatment Guidelines: 
Current recommendations are cotrimoxazole twice a day for 5 days for pneumonia 
and intramuscular  penicillin or chloramphenicol  for children with severe pneumonia. 
The  problems  of  increasing  resistance  to  cotrimoxazole  and  unnecessary  referral  of 
children with any chest wall indrawing have led to studies exploring alternative to the 
antibiotics  currently  used  in  ARI care  management.  With  respect  to  the duration  of 
antibiotic treatment, studies in Bangladesh, India and Indonesia indicate three days of 
oral co-trimoxazole or amoxycillin are as effective as five days of either drug in children 
with non-severe pneumonia (Agarwal and Others; Kartasamita 2003)27.
In  a  Multicentric  study  of  intramuscular  penicillin  versus  oral  amoxicillin  in 
children with severe pneumonia and, where supply is limited, to children with any of the 
following signs; inability to feed and drink, cyanosis, respiratory rate greater than or 
equal  to  70  breaths  per  minute,  or  severe  chest  wall  retractions.  Oxygen  should  be 
administered at a rate of 0.5 litre per minute for children younger than 2 months and 1 
litre per minute for older children. INHO recommends simple clinical signs to detect and 
treat hypoxemia. Despite there recommendations, a study of 21 first level facilities and 
district  hospitals  in  seven  developing  countries  found  more  than  50  percent  of 
hospitalized children with LRI were inappropriately treated with antibiotics or oxygen 
(Nolan and Others, 2001) and in several, oxygen was in short supply28.
LITERATURE REVIEW
i) Simple predictors to differentiate acute asthma from ARI children
Sachdev HP et al conducted a study to evaluate simple predictors to differentiate 
these two conditions to refine the recommended case management.  In a case-control 
comparison, children between 6 months to 50 months age who presented with cough and 
rapid  breathing  due  to  asthma (n=100),  ARI  (n=100)  were  evaluated.  Only  34% of 
asthmatics  had  an  audible  wheeze.  Significant  independent  predictors  on  multiple 
logistic regression analysis were, number of earlier attacks and fever (or temperature). 
The best predictor for asthma was two or more earlier similar episodes (sensitivity 84%, 
specificity 84%) followed by temperature <37.6 degree C (Sensitivity 73%, specificity 
84%). It is concluded that simple clinical predictors can differentiate acute asthma and 
ARI.
ii) Respiratory rate and signs in roentgenographically confirmed pneumonia 
among children in China.
Dai Y et  al  studied clinical  signs in the diagnosis of radiologically  confirmed 
pneumonia among 54 children under 5 years of age. The mean respiratory rate among 
children  with  cough  and  fever  was  50  breaths/min  for  infants,  40  breaths/min  for 
children aged 1-5, compared with 40/min and 30/min respectively for no pneumonia 
children.  The  researchers  deemed  these  rates  to  be  the  cutoff  criterion  for  rapid 
breathing. Nasal flaring, chest indrawing and cyanosis had high specificities.
(iii) Improving  antibiotic  and  bronchodilator  prescription  in  children  presenting 
with difficult breathing- experience from an urban referral hospital.
Sachdev Hp et al conducted a prospective observational study in urban tertiary 
care centre. Two hundred children aged between 6 months and 5 years presenting with 
difficult breathing (as defined by WHO algorithm) were prospectively evaluated for the 
diagnosis and the need for bronchodilator and antibiotic therapy.
On the basis of reliable predictors (sensitivity > 70% and specificity > 70%) of 
antibiotic and bronchodilator prescription, irrespective of the exact diagnostic category, 
two viable modifications of WHO case management algorithm emerged -  (i) previous 
similar episode of cough and difficult breathing, and (ii) fever. Acute asthma was the 
predominant condition (46% or 54%), pneumonia alone was rare (10%), co-existence of 
pneumonia with bronchospasm was more frequent (22% or 15%). The study concluded 
that  it  is  feasible  to  amalgamate  these  simple  clinical  features  in  the  WHO  case 
management algorithm to significantly refine the antibiotic (95% CI range 7% to 33%) 
and bronchodilator (35%; 95% CI 27% to 43%) prescription.
iv) Additional markers to refine the word health organization algorithm for 
diagnosis of pneumonia:
Castrol AV et al conducted a prospective study in urban tertiary care hospital to 
examine the value of history of previous respiratory distress, chest indrawing and fever 
and  response  to  bronchodilator  to  refine  these  guidelines.  Children  aged  between  6 
months  and  59  months  presenting  with  cough  and  tachypnea  (182  children)  were 
enrolled. Each child had a chest x-ray done that was read by two blinded, independent 
radiologists.  Discordance between two radiologists led to excluding 17 patients.  The 
remaining 165 children were examined for fever and/or chest indrawing and if they had 
a history of previous respiratory distress, challenged with bronchodilator. 
The  association  of  persistent  tachypnea  after  bronchodilator  and  presence  of 
pulmonary infiltrate was recorded. Pneumonia was radiologically diagnosed in 26/165 
(15.8 percent). 2/40 (5%) of children without history of previous respiratory distress had 
pneumonia. Of the 125 children with history of previous respiratory distress, pneumonia 
was  identified  in  24  (19.2%).  Persistence  of  tachypnea  after  bronchodilator  was 
associated with pulmonary infiltrate in 14/24 (58.3 percent) whereas tachypnea persisted 
in  32/101  (37%)  children  without  pulmonary  infiltrates  (p  =  0.02).  The  negative 
predictive value of resolution of tachypnea was 87%. Bronchodilator non-response was 
most useful in children without fever and or with chest indrawing to indicate pneumonia 
as the cause of tachypnea. 
This study indicates that by adding the simple procedures of a history of previous 
respiratory distress, recording of fever and chest indrawing, and observing the response 
to  bronchodilators,  pneumonia  can  be  reliably  identified  in  children  presenting  with 
tachypnea and cough. It is probable that this approach to management of children with 
cough and tachypnea could reduce unnecessary use of antibiotics.
v) White blood cell count can aid judicious antibiotic prescribing in acute 
respiratory infection
Casey et al did a prospective study in New York USA. The use of the WBC count 
was assessed, including obviating antibiotic prescription, frequency of related follow-up 
visits, and the occurrence of subsequent bacterial infections.. Of the 1956 children with 
respiratory or febrile illness enrolled, 1219 (62%) had diagnosis established by history 
and examination and 737 (38%) did not.  Of the 737 patients without an established 
diagnosis,  386  (52%)  did  not  receive  an  antibiotic  because  they  did  not  appear 
particularly ill,  their temperature was less than 101 degrees F,  and parents were not 
demanding antibiotics, leaving 351 (48%) patients who appeared ill, had a temperature 
greater than 101 degrees F, and parents were demanding an antibiotic or physicians were 
inclined to give an antibiotic.
A WBC count was performed on these 351 children; 337 children (96%) had a 
WBC count less than 15,000/mm3, and 14 (4%) had a WBC 15,000/mm3 or greater. An 
antibiotic  was  prescribed for  13  of  the  14  children with a  WBC count  greater  than 
15,000/mms.  With this  approach,  return office  visits  in the following 2 weeks were 
infrequent (13% of 737 patients), and no child had significant bacterial illness that was 
missed with selective use of WBC count testing.
vi) Role of X-ray in diagnosis of lower respiratory infection in children:
Shaikh et al study in Pakistan in children with cough and fever in  established 
clinics  were  investigated  with  oro-pharyngeal  swabs,  blood  culture,  and  chest 
radiograph. 6383 children were studied.  Of these, 1203 children had pneumonia and 
severe  pneumonia.  Chest  radiograph was  taken in  823 children  only.  45% of  these 
radiographs had signs suggestive of infection. There was no correlation between reports 
of radiograph and isolation of organisms from oro-pharyngeal swabs. Nearly half of the 
children with pneumonia and those who grew organisms from oro-pharyngeal swabs had 
normal chest radiographs. The study concluded that chest radiographs have little value 
in diagnosis of pneumonia in children less than the year of age in community level. 
vii) Assessment and management of children aged 1-59 months presenting with 
wheeze, fast breathing and/or lower chest indrawing - results of a multicentric 
descriptive study in Pakistan
Hazir T et al did a multicentric prospective study in children aged 1-59 months 
with auscultatory and audible wheeze and fast breathing and lower chest wall indrawing. 
Response to three cycles of inhaled bronchodilators and followed up on day 3 and 5.  A 
total of 1622 children with wheeze were screened from may 2001 to April 2002, of 
which 1004 (61.8%) had WHO defined non severe pneumonia, 618 (32.8%) had severe 
pneumonia. 621 (61.8%) responded to upto three cycles of bronchodilators. 
Of the 618 severe pneumonia, only 166 (26.8%) responded. Among responders, 
93  (14.9%)  in  the  non-severe  pneumonia  and  63(37.9%)  children  in  the  severe 
pneumonia group showed subsequent deterioration on follow-up. No family history of 
wheeze, temperature >100ºF and lower chest wall indrawing were identified predictors 
of  subsequent  deterioration.  This  study  concluded  that  two  thirds  of  children  with 
wheeze  are  not  identified  by  current  WHO  ARI  guidelines.  Antibiotics  are  over-
prescribed and bronchodilators are under-utilized in children with wheeze.
STUDY JUSTIFICATION
Most of the fevers with respiratory illness are virus associated and self limiting. 
Routine blood investigation and radiological imaging are not required and increases the 
cost of the treatment.
This  study  is  expected  to  describe  the  distribution  of  disease  in  fever  with 
respiratory distress in tertiary care hospital, to find additional markers to identify and 
predict pneumonia in children with tachypnoea.
AIM OF THE STUDY
 To  re-define  or  refine  tachypnea  as  a  specific  indicator  of  bacterial 
pneumonia.
 To identify other clinical predictors for identifying bacterial pneumonia.
SUBJECTS AND METHODS
The study was designed to be done in two phases. In the first phase it is to be 
carried  out  as  a  descriptive  study  of  children  presenting  with  fever  and  respiratory 
distress  in the OPD to identify  the specific  markers  for  bacterial  pneumonia.  In  the 
second phase presenting clinical features in children with radiological pneumonia will 
be analysed to validate the findings from Phase I.
Study period : Nov. 2006 to Oct. 2007
Study place : Institute of  Child Health and Hospital  for 
Children, a tertiary care hospital in Chennai
Phase I
Sample size : 100 children 
Study population: Children presenting in the out  patients department with fever and 
respiratory distress.
Inclusion Criteria:
Children in the age group 6 months to 5 years with pneumonia as defined by the 
WHO i.e. children with the following symptoms
 Fever <5 days   and
 Cough & cold < 1 week
 Age specific tachypnea with or without lung signs (wheeze or crepts) i.e.
o ≥50 breaths/min in 2 months to 11 months
o ≥40 breaths/min in 12-60 months
 Indrawing of chest
Exclusion Criteria:
• Child with severe illness as defined by WHO like not able to take oral feed, stridor in a calm child, 
severe malnutrition, convulsions, abnormal sleepy
• Children with an established diagnosis of  bronchial asthma
• Children who had similar illness in the last 2 weeks
• Antibiotics used in the last 2 weeks.
• Children with established diagnosis of other chronic illness like congenital heart disease, 
tuberculosis.
• Immunodeficient children, or on steroid therapy.
• Children with respiratory failure
• Children who were intubated and ventilated
• Children requiring inotropic support
Manoeuvre:
Children in the age group of 6 months to 5 years satisfying the above criteria were 
enrolled in this phase of the study. A lower age limit of 6 months was used because the 
diagnosis  of  hyper-reactive  airway  disease  below  this  age  is  uncommon  and  the 
likelihood of pneumonia is more in younger infants. Children attending the out-patient 
department  on  a  fixed  day  of  the  week  (Monday)  and  who  come  under  the  study 
population  during  the  study  period  were  admitted  and  recruited  in  the  study  and 
informed verbal consent for participation was taken from the parents.
Clinical and Investigative Evaluation:
The detailed clinical evaluation of these subjects, done by a single observer was 
recorded on the proforma. Special emphasis was given to symptoms like cough, fever, 
nasal discharge, tachypnea, chest indrawing, and refusal of feeds.
On physical examination:
The following were specifically looked for
• Toxic look (investigator’s impression) 
• Temperature: Axillary temperature (in degree Celsius) was recorded for 3 minutes.
• Pulse rate: Counted by palpating radial pulse for 60 seconds.
• Respiratory rate: Counted by observing the movement of chest and abdomen for 60 
seconds in an awake but quite child.
• Chest  indrawing by observing the inward movement of the bony structure of the 
lower chest wall during inspiration.
• Nasal discharge if present was classified into watery, mucopurulent or purulent.
Examine  chest  to  look  especially  for  breath  sounds  and  added  sounds  like 
crepitations  and  wheeze.  For  wheeze,  it  was  also  ascertained  prior  to  auscultation, 
whether the sound was audible without the stethoscope.
i) Abdomen- Liver and spleen were noted.
ii) Other systemic examination was also conducted.
Investigations  performed  in  all  subjects  include  chest  roentgenogram and 
total count and peripheral smear.
Treatment:
All cases admitted were given supportive treatment, which include 
• oxygen, if not maintaining saturation
• antipyretics, if febrile
• intravenous fluids, if not able to take orally,
• bronchodilators (aerosolized beta-2-agonist), or steroids if wheeze is present. 
• Normal saline nasal drops if nasal symptoms are present
The cases were monitored for any worsening or improvement every 6th hourly on day 
1 and vital parameters were monitored. When the clinical condition is not improving or 
x-ray chest suggests pneumonia, antibiotics were started. 
Radiological Evaluation:
Evaluation of the chest was done by a radiologist who was unaware of the clinical 
diagnosis.
Phase - II
Sample size: 
50 children 
Study population:
Inclusion criteria:
Children of both sexes in the age group 6 months to 60 months with radiologically 
diagnosed pneumonitis and pneumonia
Exclusion criteria:
• Child with severe illness as defined by WHO like not able to take oral feed, stridor in a calm child, 
severe malnutrition, convulsions, abnormal sleepy
• Children with an established diagnosis of  bronchial asthma
• Children who had similar illness in the last 2 weeks
• Antibiotics used in the last 2 weeks.
• Children with established diagnosis of other chronic illness like congenital heart disease, 
tuberculosis.
• Immunodeficient children, or on steroid therapy.
• Children with respiratory failure
• Children who were intubated and ventilated
• Children requiring inotropic support
Manoeuvre:
Children  attending  the  out-patient  department  on  a  fixed  day  of  the  week 
(Monday)  and who come under  this  study  population  during  the  study  period  were 
admitted and recruited in the study and informed verbal consent for participation was 
taken from the parents. Their clinical profiles were recorded as in phase I. All children 
coming under this study population were given antibiotics and supportive treatment. The 
cases were monitored for any worsening or improvement every 6th hourly on day 1 and 
vital parameters were monitored.
Diagnostic Definitions:
No universally acceptable criteria are available to objectively define pneumonia35. 
Pneumonia is known to occur without cough, respiratory distress or obvious radiological 
abnormalities.  Conversely,  infiltrative  changes  in  the  x-ray  are  possible  even  in 
bronchiolitis  or asthma35.  Since the WHO guidelines are intended to rationalize case 
management  in  a  simplified  manner  for  paramedical  personnel,  the  diagnostic 
capabilities of trained pediatricians with access to investigations could reasonably be 
considered  as  the  ‘gold  standard’  for  this  purpose.  In  this  context,  the  following 
operational definitions of pneumonia, asthma and bronchiolitis were resorted.
Pneumonia:
• Fever  of  more  than  100oF with  cough alongwith  respiratory  distress,  crepts, 
and/or wheeze    and
• Chest X-ray evidence of pneumonia.
Asthma:
First attack of wheeze after 1 year of age fulfilling following criteria:
• wheeze
• Absence of pulmonary infiltrates on chest x-ray
• Absence of polymorphonuclear leucocytosis or bandemia on peripheral smear.
• Rapid clinical improvement on bronchodilator therapy without antibiotics.
Bronchiolitis:
According to the WHO guidelines, the first attack of wheeze in early infancy is 
regarded as bronchiolitis. This definition of bronchiolitis was utilized if the peripheral 
smear failed to reveal a polymorphonuclear response or bandemia or an X ray evidence 
of bow sign was present.
STATISTICAL ANALYSIS
Results were tabulated and percentage proportion for epidemiological and clinical 
symptomatolgy were arrived.
For  both  groups  comparative  student’s  ‘t’  test  was  used  to  compare  the  data 
between the pneumonia group and no pneumonia group. p-value <0.05 was considered 
significant.
Receiver- operator characteristic (ROC) curve done for temperature, respiratory 
rate and leucocyte count was done to define cut-off point to predict pneumonia using 
SPSS software.
RESULTS
Phase – I
Children recruited with WHO defined pneumonia  - 100.
Children with WHO defined pneumonia having x-ray evidence of pneumonia – 5
Phase – II
Children identified to have x-ray evidence of pneumonia 50.
Epidemiological Data: 
PHASE I
Age Distribution
Age in Months No of Children Percentage
6-11 39 39%
12-60 61 61%
PHASE II
Age in Months No of Children Percentage
6-11 M 23 46%
12-60 27 54%
In  WHO  defined  pneumonia  group,  39  children  (39%)  were  between  6 
months to 11 months, and 61 children (61%) were between 12-60 months.
In radiologically defined pneumonia group, 23 children (46%) were in the age 
group 6-11 months  and 27 children (54%) were  in  the  age  group 12 months  to  60 
months.
Sex Distribution:
Phase
Male Female
No. % No. %
Phase I 56 56 44 44
Phase II 26 52 24 48
There  was  equal  distribution  of  the  study  population  between  both  the 
sexes.  No  sexual  preference  was  noted  in  ARIs.  In  child  with  WHO  defined 
pneumonia, there were 56 males (56%) and 44 females (44%). In radiologically 
defined  pneumonia  group,  there  were  26  male  children  (52%)  and  24  female 
children (48%).
The male female ratio was 56:44 (1.27:1) in the phase I study, and 52:48 (1.08:1) 
in the phase II study. This difference is not statistically significant.
Clinical Examination:
Symptoms and signs
Phase I
n=100
Phase II
n=50
No. Percentage No Percentage
Cough 100 100% 50 100%
Tachypnea
(age specific)
100 100% 50 100%
Fever 63 63% 43 86%
SCR/ICR 68 68% 38 76%
Crepitations 88 88% 50 100%
Wheeze 82 82% 11 22%
Nose block / Discharge 76 76% 14 28%
Stridor 2 2% 0 0%
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In Phase I study group, tachypnea and cough were present in all children. Fever 
was present in 63% and subcostal and intercostal retractions were identified in 68%. 
Wheeze and crepitations are seen in 82% and 88% respectively. Majority of the children 
had nasal block or nasal discharge (76%). The above-said symptoms were significantly 
higher in the phase I study than the phase II study.
In phase II study, cough, tachypnea and crepitations were seen in all  children. 
Fever  was  the  predominant  symptom  in  86%  and  retractions  in  76%  of  the  study 
population.
In WHO defined pneumonia group, leucocytosis was present in 22 children.(22%)
In radiologically defined pneumonia group, 36 children (72%) have leukocytosis.
Total Count
Normal Abnormal
n % n %
Phase I 78 78% 22 22%
Phase II 14 28% 36 72%
X-ray Findings in Phase I: n %
Bronchiolitis 34 34%
BHI
61 61%
Bronchopneumonia 5 5%
Comparisons of children with no pneumonia and pneumonia
In view of the fact that majority of the x rays were normal and we have a group 
where there is a x ray evidence of pneumonia, an attempt was made to define those who 
are likely to have bacterial  pneumonia with the three parameters namely, respiratory 
rate,  fever and leukocytosis.
Comparison of parameters in the 6-11 months age group
Parameter
Mean + SD
No pneumonia Pneumonia
p-value
RR 55 + 2 56 + 2 0.00
Temperature 37.1+ 0.7 38.2 + 0.5 0.00
WBC 14418 + 2568 17708 + 1750 0.00
 
Mean respiratory rate for 6-11 months were 55 ± 2 in no pneumonia group and 56 
±  2  in  pneumonia  group.  Mean  temperature  for  6-11  months  were  37  ±  0.7  in  no 
pneumonia group and 38.2 ± 0.5 in pneumonia group. Mean leukocyte count for 6-11 
months were 14418 ± 2568 in no pneumonia group and 17708 ± 1750 in pneumonia 
group. 
Comparison of parameters in the 12-60 months age group
.Parameter
Mean + SD
No pneumonia Pneumonia
p-value
RR 44 + 2 46 + 2 0.04
Temperature 37.2+ 0.8 38.2 + 0.4 0.00
WBC 12016 + 2638 15304 + 2148 0.00
Mean respiratory rate for 12-60 months were 44 ± 2 in no pneumonia group and 
46 ± 2 in pneumonia group. Mean temperature for 12-60 months were 37.2 ± 0.8 in no 
pneumonia group and 38.2 ± 0.4 in pneumonia group. Mean leukocyte count for 12-60 
months were 12016 ± 2638 in no pneumonia group and 15304 ± 2148 in pneumonia 
group.
Development of ROC for predicting RR cutoff value for 6 – 11 months.
The  ROC  was  developed  to  predict  the  cut-off  values  for  respiratory  rate, 
temperature and leukocytosis. 
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The best cut off lies at 53.5 with a sensitivity of 83% and specificity o 68.9%
An  area  of  0.83,  for  example,  means  that  a  randomly  selected  child  with  
pneumonia has a RR larger than that for a randomly chosen child without pneumonia 
83% of the time.
Development of ROC for predicting RR cutoff value for 12 months – 60 months
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An  area  of  0.69,  for  example,  means  that  a  randomly  selected  child  with  
pneumonia has RR larger than that for a randomly chosen child without pneumonia 
69% of the time.
Development of ROC curve for temperature between 6 months -11 months.
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Development of ROC curve for temperature between 12 months -60 months.
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Development of ROC curve Leucocytosis for 6 months – 11 Months
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.
Development of ROC curve Leucocytosis for 12 months – 60 Months
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The best cut off lies at 13650 with a sensitivity of 73% and specificity of 74.5%
Accuracy is  measured by the area under  the ROC curve.  An area of  1  represents  a 
perfect test; an area of .5 represents a worthless test. A rough guide for classifying the 
accuracy of a diagnostic test is the traditional academic point system: 
• .90-1 = excellent (A) 
• .80-.90 = good (B) 
• .70-.80 = fair (C) 
• .60-.70 = poor (D) 
• .50-.60 = fail (F)
Outcome:
Children  with  no  pneumonia  treated  only  with  supportive  care  showed 
symptomatic improvement in wheeze and respiratory distress in 10-14 hrs with quick 
response  to  bronchodilators  and  in  bronchiolitis  within  24-48  hrs  and  in 
bronchopneumonia within 2-4 days. No deaths were observed in both the study groups.
                                               
                                                       DISCUSSION
Pneumonia  has  been  a  major  cause  of  mortality  in  under  five  age  group, 
accounting for 14.3% deaths in infancy and 15.9% during 1-5 years. Pneumonia was 
mainly diagnosed by clinicians based on clinical findings and x-ray evidence. Majority 
of the children in developing countries do not have access to either a skilled person or to 
radiological investigations. By the time they reach either of these, it is too late for the 
child with many fold increase in risk of mortality. 
It was such a scenario that various clinical parameters were assessed by various 
group of researchers, age specific tachypnea was identified as the single most sensitive 
indicator  of  pneumonia.  Various  community  based  study  proved  (The  Papua  New 
Guinea study, (Shann, Hard and Thomas, 1984)26 and Cherian and others, 1988 in India 
and (Mulholland and others,  1992)19.  On the basis of these and other data (Cambell, 
Byass and others 1989), Kolstad and others, 1997, Perkins and others, 199716 , Redd 
1994, Simoes and other 1997,24 Weber and others, 1997). WHO recommends respiratory 
rate cut-off 50 breaths per minutes for infants age group 11 months and 40 breaths per 
minute age 12 months to 60 months). 
The skill of simple counting of respiratory rate can be easily acquired by health 
care  provider  at  primary  health  centre  level.  WHO  developed  algorithm  for  ARI 
management based on tachypnea, chest indrawing and danger signs. This WHO based 
protocol  has  been  very  effective  in  reducing  mortality  due  to  pneumonia.  However 
tachypnea was not a specific indicator and could be due to other conditions like viral 
pneumonias and bronchiolitis and allergic airway disease etc.
In India, especially in southern states, the last decade has witnessed rapid phase of 
industrialization, change in life style and upward mobility of the populations. Industrial 
houses have been setting up factories in rural areas thereby increasing the changes of 
pollution and hyper-reactive airway disease. In such a scenario, it is but natural for more 
cases of hyper-reactive airway disease and viral pneumonia to occur. 
It is against this background that WHO defined pneumonia was revisited by this 
study to refine the parameters in order to filter  out allergic airway disease and viral 
pneumonia.  Over-use  of  antibiotics  and  non-usage  of  supportive  measures  like 
nebulization could result in higher cost and morbidity and mortality.
Pneumonia  and other  airway  disease  affect  the  infants  much more  than  older 
children. This has been proved in study conducted by V.P.Reddaiah and S.K.Kapoor38 in 
AIIMS in India.   47.7% of pneumonia occur in infants.  87.7% occurred in children 
below 3 years. Males had a relatively higher incidence of pneumonia (0.32 Vs 0.27).
And it has been confirmed by this study. In our study, the infants constituted 46% 
of the total pneumonias and the 12 to 60 month age group constituted 54%. There is no 
sex  prediction  for  the  affliction  with  airway  illness.  Clinical  triad  of  fever, 
breathlessness,  and  cough  is  common  to  both  the  groups  as  proved  by  our  study. 
However among the No pneumonia group, fever, wheeze, and nasal discharge seem to 
be the commonest presentation. N.Shimojo et al39 study found that the association of 
wheezing illness with allergic rhinitis is about 35 to 48%.
Three  clinical  parameters  respiratory  rate,  fever  and  one  lab  parameter, 
leukocytosis  are  found  to  be  significantly  different  between  pneumonia  and  no 
pneumonia group especially after nebulisation. Thus if  tachypnea, which is a simple 
clinical  parameter  which  can  be  easily  practised  in  primary  care  settings  can  be 
redefined  and  temperature,  again  a  simple  clinical  parameter  which  can  be  easily 
practised to identify bacterial pneumonias, it could cause a significant reduction in cost 
of management and over-use of antibiotics and better utilization of supportive therapy.
Receiver-operator  characteristic  curve  was  developed  for  the  parameters  of 
tachypnea, fever and leukocytosis.
For the children 6-11 months, respiratory rate of 53.5 and above was found to 
predict pneumonia with a sensitivity of 83% and specificity 68.9% (95% C.I = 0.72, 
0.93) (p-value:0.00).
For children 12-60 months cut-off rate of 43.5 with a sensitivity of 80.8% and 
specificity of 45.5% (95% C.I. = 0.56, 0.81) (p-value:0.01).
For  children  6-11  months,  temperature  37.6ºc  and  above  was  found  to  best 
predictor of pneumonia with sensitivity of 88% and specificity of 73.3% (95% C.I. = 
0.79, 0.90) (p-value: 0.00).
For children 12-60 months, the best cut-off value of temperature at 36.6ºc and 
above  with  sensitivity  of  92%  and  specificity  of  67.3%  (95%  C.I.=0.74,  0.91)  (p-
value:0.00).
For children 6-11 months, leukocytosis of 16250 and above was found to predict 
pneumonia with sensitivity of 75% and specificity of 80% (95% C.I.= 0.76, 0.94) (p-
value: 0.00).
For the children 12 months to 60 months, leukocytosis of 13650 and above with 
sensitivity of 73% and specificity of 74.5% (95% CI=0.74, 0.91) (p-value = 0.00).
The similar study done by Naresh Kumar et al 40 in a tertiary care hospital found 
that 88% infants having bronchopneumonia had fever >100ºF and only 12% infants had 
temperature <100ºF. Presence of fever >100ºF had a sensitivity of 88% and specificity 
of 76% in the diagnosis of bronchopneumonia in a child having respiratory distress and 
wheeze.  Leukocyte  count  was  elevated  in  17500  in  36  children  in  50  cases  of 
bronchopneumonia with sensitivity of 72% and specificity of 100%.
Hence  it  is  concluded  by  the  study  that  any  child  <1  year  presenting  with 
respiratory rate ≥54 / minute and having temperature of 37.6ºc and above more likely 
suffer  from pneumonia especially  if  rate is  counted after  nebulisation.  Similarly  any 
infant presenting with running nose, audible wheeze, respiratory rate <54, temperature 
<37.6°C is likely to present with viral or allergic airway disease. Especially the rate is 
recorded after nebulisation and x-ray if the situation warrants. 
Likewise in children in the age group 12-60 months , respiratory rate ≥44 and 
temperature ≥37.6°C are more likely to have pneumonia especially if the rate is counted 
after nebulisation. 
Additionally, if lab support is available, leukocytosis >16250 and >13650 with 
above clinical signs in a child can reasonably predict that the child is suffering from 
bacterial pneumonia in 6-11 months and 12 to 60 months respectively.
The study recommends that nebulisation services be made available in primary 
health centers and redefined tachypnea as an indicator of pneumonia if respiratory rate is 
>54 in infants and >44 in children between 12-60 months even after nebulisation. 
Limitation of the study
This study needs to be validated in community settings by the primary health care 
provider.
Different geographical represents and presence or absence of pollution may alter 
the predictive ability of the tachypnea.
CONCLUSION
It  can  be concluded from the study that  hyper-reactive  airway disease can be 
differentiated from pneumonia, to a reasonable extent on the basis of clinical features 
like fever, RR, and simple investigation like leukocyte count. This may help in rational 
management with antibiotics, bronchodilators and steroids in these children. This study 
offers possibility of redefining the current algorithm by incorporating simple predictors 
that have potential application to the para-medical personnel. Our study indicates the 
need  for  initiating  multi-centric  trials  in  diverse  settings  to  confirm  or  refute  the 
findings. 
A confirmation has practical implication for refining the current case management 
of a child presenting with difficult breathing. In this context, the feasibility of simplified 
delivery  of  aerosolized  bronchodilator  therapy  through  a  metered  dose  inhaler  and 
nebulizer  merits  exploration.  Prevention  of  over-use  of  antibiotics  and  the  obvious 
economic advantage are the major advantages of the refined / re-defined algorithm used.
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PROFORMA
Name :
IP No. :
Age :
Sex :
Date of Admission:
Clinical Findings Day 1 Day 2 Day 3 Day 4 Day 5
Fever
RR
Cough
Nose  Block  or 
Discharge
SCR/ICR
Wheeze
Crepts
Others
Investigations:
TC :
DC :
PS :
XRAY Chest Report :
Diagnosis :
Treatment :
Date of Discharge :
